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Summary The need to inform patients using validated scientiﬁc data is acknowledged inter-
nationally. The obligation to inform patients is based on a fundamental principle of French law:
the principle of the unavailability of the human body. Before engaging in diagnostic or thera-
peutic strategies such as paediatric cardiac catheterization, the healthcare professional must
explain the disease, the advantages and drawbacks of each treatment strategy and their fore-
seeable beneﬁt/risk ratio in order to help older children and their parents come to a decision.
To obtain this required consent and before the care is provided, the infant and their legal repre-
sentative must have received clear, accurate and understandable information. An information
sheet cannot substitute for verbal information. Guidelines for good practices on the delivery
of information have been established by the Health Authorities and ofﬁcially recognized in a
decree from the Ministry of Health. These documents allow professionals to draft a written
information document for patients and healthcare users. This document must help the patient
to take part in decisions that concern them. The law of 4th March 2002 regarding the rights
of patients and the quality of the healthcare system states that ‘in cases of litigation, it is
the responsibility of the professional or the healthcare establishment to provide proof that the
information was given to the person concerned in the conditions set out in the present article.
This proof can be brought by any means’.
© 2013 Elsevier Masson SAS. All rights reserved.Abbreviations: ALARA, As low as reasonably achievable; BW, Body weight; CC, Cardiac catheterization; DNA, Deoxyribonucleic acid;
AS, Haute Autorité de santé; PHC, Public health code.
∗ Corresponding author. Fax: +33 3 80 29 39 04.
E-mail address: caroline.bonnet@chu-dijon.fr (C. Bonnet).
875-2136/$ — see front matter © 2013 Elsevier Masson SAS. All rights reserved.
ttp://dx.doi.org/10.1016/j.acvd.2013.01.007
Paediatric cardiac catheterization: An information sheet 229
MOTS CLÉS
Cardiopathies
congénitales ;
Cathétérisme
cardiaque ;
Enfants ;
Brochure
d’information ;
Complications
Résumé La loi du 4mars 2002 du Code de la santé publique dispose que : « L’information du
patient incombe à tout professionnel de santé ». L’obligation d’information des patients repose
sur un principe fondamental du droit franc¸ais : le principe d’indisponibilité du corps humain.
Pour obtenir le consentement indispensable et préalable aux soins, le patient (ou son représen-
tant légal pour le mineur) aura du recevoir une information claire, loyale et adaptée. Avant un
cathétérisme cardiaque pédiatrique, il incombe aux professionnels d’expliquer la pathologie,
les avantages et les inconvénients de chaque stratégie, la balance bénéﬁces/risques prévisi-
bles des thérapeutiques pour aider l’enfant en âge de comprendre et ses parents à donner leur
consentement. Une sheet d’information complète l’information délivrée oralement mais ne la
remplace pas. Des recommandations des bonnes pratiques sur la délivrance de l’information ont
été établies par la Haute Autorité de santé et homologuées par arrêté du ministre de la Santé.
Ces documents permettent aux professionnels d’élaborer un document écrit d’information à
l’intention des patients et des usagers du système de santé. Ce document doit aider le patient
à participer aux décisions qui concerne sa santé. En cas de dommages liés aux soins survenus
dans le cadre d’un aléa thérapeutique, l’indemnisation des victimes, s’il y a eu un défaut
d’information, sera pour partie à la charge de l’établissement ou de son assureur puisque le
défaut d’information est constitutif d’une faute.
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Introduction
The incidence of congenital heart disease is less than 1%.
Overall, three out of 1000 live births will have congenital
heart disease that will require an immediate intervention,
including cardiac catheterization (CC) and surgery [1]. CC
should be used in any circumstance in which the anatomy of
the heart of a child with congenital heart disease is inade-
quately deﬁned by non-invasive means. On some occasions,
particularly in very complex lesions, more speciﬁc details
about the anatomy or haemodynamic features are neces-
sary. Paediatric CC is a safe and effective procedure used to
obtain detailed information about heart anatomy as well as
to repair the heart without surgery. Advances in non-invasive
imaging have allowed CC to become increasingly a catheter-
based therapeutic option rather than a diagnostic tool.
Paediatric CC has evolved to include a variety of inter-
ventional procedures, including the closure of atrial septal
defect, the closure of ventricular septal defect, the clo-
sure of patent ductus arteriosus, the creation of holes such
as septostomy, angioplasty, valvuloplasty, the placement of
stents to open up narrowed vessels, the embolization of
vessels such as collateral vessels or, more recently, the
replacement of heart valves [2—5].
Paediatric CC is not without risk to the patient. In the
last decade, there have been signiﬁcant improvements in
technology and equipment. Nonetheless, the risk of compli-
cations remains and these risks adversely affect outcomes.
Healthcare professionals have to explain to
patients/parents why they intend to carry out a par-
ticular diagnostic test or a procedure, such as CC. We
propose to review the purpose of the information sheet for
paediatric CC.
Concept in terms of medical ethics: notion
of autonomy
Autonomy from the Greek autos ‘one’s self’ and nomos
‘rule’ designates the power of persons to make decisions
a
ds droits réservés.
hat concern themselves. To be autonomous, a person must
e able to evaluate his/her options rationally, accord-
ng to the facts and taking account of the consequences
6—8].
Since the 1970s, the relationship between doctors and
heir patients has evolved considerably. The concept of
utonomy of the patient has substantially changed the
ractice of medicine and the paternalistic notion that
the doctor is always right’ has fallen by the wayside.
n the past, the doctor ‘spared’ the patient the respon-
ibility of decision. Today, doctors must provide patients
ith information. They must help them to make informed
hoices. They must abide by their choice to refuse treat-
ent. They must withhold nothing from their patients.
octors cannot impose their desires and preferences on
hose of the competent patient. Currently, patients are
onsidered Persons, with, as the corollary, the emergence
f patients’ rights [9,10]. Patients have become ‘actors’
ith regard to their health, free to decide for them-
elves.
Modern healthcare ethics is based on the following con-
epts: benevolence, autonomy, absence of malice, equity
nd responsibility. The health authorities (Haute Autorité de
anté [HAS]) and healthcare policy emphasize the ‘absence
f malice’ or rather ‘good treatment’ as the appropri-
te healthcare attitude, which should be professional,
ctive and dynamic, individual and collective and have
ts roots in human values. It is based on ‘good manners’
11].
The European concept of autonomy is accompanied by
otions of vulnerability, dignity and integrity. This is an
ssential notion in that it makes the person a moral actor.
onsent is the unequivocal condition in the principle of
utonomy. Consent must be obtained only after the infor-
ation has been given to and received by the patient. This
ssumes that the patient must be able to understand and
ssimilate the information [7,12,13].Technical advances in the world of medicine and the
pprehension of society as a right make it more and more
ifﬁcult to apply the concept of autonomy strictly.
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urpose of information sheets
he need to inform patients using validated scientiﬁc data
s acknowledged internationally. The Council of Europe
cknowledges ‘the right of patients and citizens to be pro-
ided with and to have easy access to relevant information
bout their health and healthcare in a format and lan-
uage they can understand’. This information should be
ased on scientiﬁc data derived from practice guidelines
nd be made available in formats suited to several target
udiences (healthcare professionals, patients and decision-
akers) [12—14].
articularities of French legislation
he obligation to inform patients is based on a fundamental
rinciple of French law: the principle of the inviolability and
nalienability of the human body.
This principle is deﬁned in article 16-3 of the Civil Code,
hich stipulates that ‘the integrity of the human body can-
ot be interfered with except for the medical needs of
hat person or exceptionally in the therapeutic interest of
thers. The consent of the person concerned must be col-
ected beforehand, unless the state of the person makes it
mpossible for him/her to provide consent for the necessary
herapeutic intervention’ [15].
To obtain this required consent and before the care
s provided, the patient (or their legal representative for
inors) must have received clear, accurate and understand-
ble information [9,10].
Article 3 of the Charter for Hospitalized Persons states
hat the information given must be ‘understandable and
ccurate’. Hospitalized persons take part in the therapeutic
hoices that concern them. They can be assisted by a person
f trust whom they can choose freely. A medical act can only
e performed once the patient has freely provided informed
onsent. The patient has the right to refuse any treatment
16].
The law relative to patients’ rights and the quality of the
ealthcare system, enacted on 4th March 2002 [17], made it
ossible to incorporate into the Public Health Code the pro-
edures to follow with regard to information and patients’
onsent. The principles are based on the Hedreul jurispru-
ence resulting from a Supreme Court decision dated 25
ebruary 1997 [18].
In accordance with the law of 4th March 2002, the health-
are professional is obliged to provide information about all
f the risks unless they are benign or rare. This informa-
ion can be provided orally unless the law states otherwise.
ritten consent is necessary in the following situations:
medical assistance for procreation;
donation and utilization of elements and products of the
human body;
the taking of organs for transplants;
samples taken for scientiﬁc purposes;
voluntary termination of pregnancy;
genetic examinations;
fallopian-tube sterilization;
biomedical screening; and research [17].
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aediatric cardiac catheterization: an
nformation sheet
t is not compulsory to obtain written consent before medi-
al acts such as paediatric CC, but as it is a procedure
erformed on a minor, it is recommended to have both par-
nts sign a document authorizing the treatment in order to
nsure traceability. Consent must be obtained only after
lear understandable information has been provided ver-
ally or in writing by the practitioner during a speciﬁc
nterview [9,10,15].
The laws and recommendations have encouraged the
evelopment of good practices. Through a series of
uestions, we propose to help practitioners respond appro-
riately in certain situations of conﬂict or in medical
mergencies.
n paediatric cardiac catheterization, to
hom must the information be given and
ho must provide the consent?
hatever the minor’s family situation, both parents must
e consulted, in principle, if they are joint holders of
arental authority. Unless otherwise decided by a judge,
ivorced or separated parents jointly exercise parental
uthority.
The person the information is given to is the patient,
ho may be a minor or an adult under guardianship, in
hich case the information must be adapted to their level
f maturity and their faculties of discernment. Holders of
arental authority will also be informed unless the minor
bjects.
Article L1111-2 of the Public Health Code (PHC) states
hat: ‘This information bears on the different investiga-
ions, treatments or preventive actions that are proposed,
heir usefulness, the immediate need if necessary, their
onsequences, the foreseeable frequent or serious risks
hey carry and other possible solutions and the foreseeable
onsequences in case of refusal. When, in the wake of inves-
igations, treatments or preventive actions, new risks are
dentiﬁed, the person concerned must be informed about
hem, unless the person cannot be traced’ [19].
Article L1111-2 of the PHC states that: ‘Every person has
he right to be informed about his/her state of health. It
s incumbent on every healthcare professional to provide
his information in accordance with his/her expertise and
n the respect of professional rules that apply to him/her.
nly emergencies or the impossibility to inform the patient
elease the professional from this obligation. This informa-
ion is delivered during an individual interview. The wish of
ersons not to be informed about a diagnosis or prognosis
ust be respected, unless third parties may be exposed to
risk of transmission. The rights of minors or adults under
uardianship mentioned in the present article are exercised,
epending on the case, by those with parental authority or
y the legal guardian. These will receive the information
rovided for in the present article, subject to the provi-
ions set out in article L1111-5. The parties concerned have
he right to receive the information themselves and to take
art in making decisions that concern them, in a manner
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that for minors is in keeping with their level of maturity,
and for adults under guardianship, that is in keeping with
their faculties of discernment’ [17,19,20].
What is the procedure if the holders of
parental authority are separated or
divorced?
Article R4127-42 of the French PHC stipulates that ‘divorced
or separated parents jointly exercise parental authority,
unless the judge has decided otherwise. Divorced or sep-
arated parents therefore exercise parental authority jointly
and must both be informed and consulted for major deci-
sions concerning their child’ [21].
Article 372-2 of the French Civil Code speciﬁes that ‘in
the view of a third party acting in good faith, each of the
parents is considered to act with the agreement of the other,
when he/she alone effects a usual act of parental authority
for the child’ [22].
CC cannot be considered a usual act in the eyes of the
law.
How must the information on cardiac
catheterization be communicated?
Verbal information is essential and must be adapted to each
individual. It is necessary to spend time to be patient, to
listen carefully and, if needs be, to modulate the informa-
tion depending on the situation of the child and their family.
A document or comprehensive information sheet is a com-
plement to the verbal information given by the healthcare
professional but in no way replaces it. The sole aim is to give
written information to the child and the parents so that they
can think about the situation after the interview; it is not
necessarily given for the parents or their representatives to
sign. There must be no statement obliging the patient to
sign.
It is recommended to provide objective information with-
out dramatizing the situation or expressing undue optimism
according to the following principles:
• give quantitative information about the frequency of the
disease or its symptoms;
• describe the beneﬁts/risks and the consequences of treat-
ments on the patient’s everyday life;
• propose a list of questions that the patient can ask a
healthcare professional;
• indicate sources of complementary information;
• clearly mention the authors of the information, the dif-
ferent ﬁelds they work in, the sources of information and
any funding, as well as the date the document was drawn
up.
Generally, this information is given at the time of the
interview with the parents and the infant. Written consent
is not compulsory. In the majority of cases the information
covers the following points:
• the indication;
• the procedure itself;
• the objectives;
m
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the risks;
possible complications.
As often as possible, if the child’s state of health allows,
he parents and the child if they are old enough to under-
tand must be given a period of reﬂection between the time
he information is provided and the procedure itself [23].
ow are the information sheets and
onsent forms drawn up?
uidelines for good practices on the delivery of information
ave been established by the HAS and ofﬁcially recognized
n a decree from the Ministry of Health. These documents
llow professionals to draft a written information document
or patients and healthcare users. This document completes
he information provided orally by the healthcare profes-
ional, but in no way replaces it. This document must help
he patient to take part in decisions that concern their
ealth. These guidelines are available on the Internet site
f the HAS. Advice based on published studies and patients’
references concerning the presentation of these written
ocuments and about writing them is also available [23]
Table 1).
The French Society of Cardiology has proposed an exam-
le of a written consent form for CC [24]. It is up to every
rofessional to tailor their own information sheet, alternat-
ng text, scientiﬁc references and diagrams to explain as
learly as possible to the parents and to children old enough
o understand the indication for the examination, the objec-
ives, the risks and the complications of CC, whether for
iagnostic or interventional purposes.
Concerning the information, it is always useful to refer
o the recommendations of the French Code of Medical
thics, which stipulates in article 35 that ‘the doctor must
rovide to persons [. . .] being treated [. . .] accurate, clear
nd understandable information on their state, and the
nvestigations and care proposed. [. . .] the doctor takes
nto account the personality of the patient when giving
hese explanations and makes sure they are understood’
10].
an emergency cardiac catheterization be
erformed if the parents are not available
o receive the information and give their
onsent or if they oppose the procedure?
hen the parents are absent and cannot be contacted by
odern means of communication (mobile phone, fax, mes-
age recorded by the emergency services, etc.) and if the
ituation is serious and an emergency, the practitioner must
ake the necessary steps to provide the care under his/her
ersonal responsibility. This is the sense of article L1111-
of the French Public Health Code, which stipulates that
he ‘doctor called upon to provide care to minors [. . .] must
ake every effort to contact the parents or the child’s legal
epresentative and obtain their consent. In cases of emer-
ency, and if the guardians cannot be contacted, the doctor
ust provide the necessary care’ [25,26].
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Table 1 Patients’ and users’ preferences with regard to brochure presentation: Haute Autorité de santé/Guidelines
Department/June 2008.
Yes No
Positive, reassuring, encouraging, optimistic,
constructive tone/mood
Negative, alarmist tone, focusing too much on what
is wrong
Honest, practical, understanding, not condescending
tone/stance
Unrealistic, glosses over real problems and possible
after effects, overoptimistic, childish
Personalized tone: talks to ‘you’, treats you as an
individual, warm, womanly, human touch
Impersonal tone: talking about patients in general,
impersonal, cold, distant, too formal
Clear vocabulary, easy to read and understand, plain
speaking, simple
Complicated language and explanation, too
technical, badly written
Short sentences, explanation of terms Dense text, too long, lacking any structure
Structured and concise text, clear headings,
important sections highlighted, short block of text
Small print, hard to read, unattractive layout, boring
presentation
Legible font size Amateurish, looks ‘cheap’, appearance of
cost-cutting
Professional-looking production
Balanced mix of text and illustrations
i
s
a
f
c
a
a
ﬁ
w
a
e
a
t
p
a
t
g
W
o
p
a
T
p
C
c
e
f
n
t
a
p
t
o
[
i
1
s
h
t
a
[
i
t
c
h
b
t
c
p
d
a
a
i
c
a
p
W
rKing’s Fund focus group discussions [23].
This does not release the doctor from the obligation to
nform minors according to their level of maturity and to
eek their consent if they are able to express their wishes
nd contribute to the decision; this is particularly the case
or teenagers [19].
If the parents refuse the procedure proposed and the pro-
edure is not urgent, it is useful to provide the information
nd give the parents time to think carefully about the situ-
tion and the information provided before they make their
nal decision.
In contrast, if the parents refuse the medical procedure,
hich needs to be performed quickly, the doctor cannot
ccept a single refusal. In such cases, the doctor must make
very effort to convince the parents by providing once again
ll the necessary information and details and by making sure
hat they have been correctly understood. The doctor must
ropose seeking the opinion of a colleague.
If the parents reiterate their refusal, the doctor can only
ct if the minor’s health or life is in danger. In such cases,
he Public Prosecutor must be informed and minor must be
iven the necessary care [9].
hat can be done if the minors explicitly
ppose the presence of the holder(s) of
arental authority at the consultation so
s to keep the state of health secret?
he law of 4th March 2002 provides for the derogation of
arental authority as deﬁned in article 371-2 of the Civil
ode. By this means, the doctor can proceed without the
onsent of the holders of parental authority when minors
xplicitly ask the doctor to keep their state of health secret
rom their parents and when the treatment or procedure is
ecessary for their health. These two conditions are cumula-
ive and the derogation provided for by the law must remain
n exception to the principle of obtaining the consent of the
arents [17,18,20,25].
c
I
aThis right of minors to secrecy also applies to the consul-
ation of their medical record by their parents. Minors can
ppose giving their parents access to their medical records
17].
This new provision falls within the recognition of the legal
ndependence and the speciﬁc rights of children, declared in
990 by the Convention for the Rights of the Child. Article 12
tates that children are capable of discernment, that they
ave the right to express their opinions freely on any matters
hat concern them and that their opinion must be taken into
ccount depending on their age and their level of maturity
27].
This possibility provided for by the law puts the doctor
n a ‘rather uncomfortable’ situation. It is for this reason
hat the doctor must always make every effort to obtain the
onsent of the minor during a consultation attended by the
olders of parental authority; in cases of reiterated refusal
y the parents, the minor must, during medical consulta-
ions and procedures, be accompanied by an adult of their
hoice.
Here, the responsibility of the practitioner consists in
roviding full information to the minor on the gravity of the
ecision to exclude the holders of parental authority and in
scertaining the identity and quality of the adult chosen to
ccompany the minor [20,25].
In the case of CC, it is difﬁcult to imagine not involv-
ng the parents in the consultation and not obtaining their
onsent for the procedure. These provisions, which can be
pplied in principle, do not seem to be realistic in the
resent case.
hat can be done if the parents refuse to
ead or to listen to the information
oncerning the risks of catheterization?
f one or both parents do not wish to know the modalities
nd the risks of a diagnostic or therapeutic procedure such
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as CC, the derogation set out in the Code of Medical Ethics
cannot be applied. Indeed, signed consent is not valid if no
precise detailed verbal information was given beforehand.
In any case, this must be reported in the child’s medical
record.
In cases other than a medical emergency, the examina-
tion must, if possible, be postponed until the information
can be provided and signed consent can be obtained from
the parents and the child who is old enough to understand.
The healthcare professional can seek assistance from the
legal expert of the establishment.
Is it necessary to list all of the risks of
paediatric cardiac catheterization and the
potential complications, with the risk that
parents may refuse the procedure?
The doctor/patient relationship is based on conﬁdence.
Withholding information, notably on the risks of paediatric
CC, would jeopardize this relationship and may lead to legal
repercussions. Information on the indication, the modalities
of the examination and its risks is provided during the suc-
cessive consultations and ideally during speciﬁc interviews
with the child and the parents. In our society, which values
fast action and results, it is necessary to give the parents and
child time to think about the information provided. This, of
course, is not possible in emergency situations. The hospi-
tal practitioner must adapt his explanations to the different
situations.
What are the legal implications?
The traceability of information given to the patient or
his/her legal representative, the content of the patient’s
medical record and recording the consent for care are major
legal issues.
Indeed, in the absence of medical malpractice or techni-
cal errors in carrying out a medical act, which nonetheless
led to a prejudice for the patient (therapeutic misadven-
ture), patients and their legal advisors may seek possible
shortcomings in the delivery of information: ‘If I had been
informed of the risks associated with this procedure, I would
never have accepted it’.
In cases when a fault-free prejudice related to a
medical act occurs, compensation for the victim is the
responsibility of the Ofﬁce National d’Indemnisations des
Accidents Médicaux. In contrast, if there was a shortcom-
ing concerning the information, compensation is paid in
part by the healthcare establishment or by its insurer, as
an error with regard to the information is considered a
fault.
The law of 4th March 2002 regarding the rights of patients
and the quality of the healthcare system states that ‘in cases
of litigation, it is the responsibility of the professional or the
healthcare establishment to provide proof that the informa-
tion was given to the person concerned in the conditions set
out in the present article. This proof can be brought by any
means’ [17,18].
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hat about information to be given after
he prejudice?
he declaration of a healthcare-related prejudice is not
nly a moral and ethical duty, but also a legal obligation.
ccording to Article L1142-4, ‘Any person who is a victim
r considers themselves a victim of a prejudice related to
n act of prevention, diagnosis or healthcare or their ben-
ﬁciaries, if the person died, or, if necessary, the person’s
egal representative, must be informed by the professional,
he healthcare establishment, the healthcare services or the
rganization involved in the circumstances and the causes
f this prejudice. This information must be provided within
weeks at the latest following the discovery of the prejudice
r at the explicit request of the person, during an inter-
iew during which the person can be assisted by a doctor or
nother person of their choice’ [28].
Patients have a fundamental right to be informed follow-
ng any prejudice.
In addition, the V2010 certiﬁcation procedure for health-
are establishments, based on legal texts, stipulates that
information to the patient in cases of a prejudice related
o healthcare’ is a requirement in the care of patients (cri-
erion 11.c) [29].
Any ‘adverse event’ that leads to a physical or psycho-
ogical prejudice must be declared, whether it is subsequent
o the complications related to the patient’s disease, to a
herapeutic accident or to an error.
The gravity of the prejudice will be assessed from the
atient’s point of view and not that of the healthcare
rovider, who may tend to minimize the repercussions.
In order to help healthcare professionals in this difﬁcult
nd often distressing situation for the teams and families, in
arch 2011 the HAS issued a guide for healthcare profession-
ls working in healthcare establishments or in other types
f practice. The guide is entitled ‘Improvement in practices
nd the safety of patients: declaration of a healthcare-
elated prejudice’ [30].
We found no jurisprudence concerning inadequate infor-
ation before paediatric CC.
hat are the possible risks and
omplications in paediatric cardiac
atheterization?
n any case requiring paediatric CC, whether there is an
nterventional act or not, the doctor is obliged to give a
aximum amount of information.
Adverse events can occur throughout the CC procedure,
rom premedication for sedation, vessel puncture and diag-
ostic CC to therapeutic interventions. The following are
he most common complications: exposure to ionizing radi-
tion (decreasing with newer equipment); risk of general
naesthesia (when used); hypothermia (especially in small
atients); aggravation of hypoxaemia; arrhythmia (tem-
orary or even permanent instability, as in heart block);
ascular injury, perforation or tears. Other complications
nclude cardiac perforation, cardiac valve injury, blood
oss that requires transfusions, thromboembolism, allergic
eaction (to contrast agents, drugs or anaesthetics), renal
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nsufﬁciency (caused by contrast agents), diffuse central
ervous system injury, stroke and death [31].
According to recent studies, diagnostic CC and inter-
entional procedures are associated with a low risk of
evere complications (1.91—9.3%) and a low mortality rate
0.14—0.29%) [32—37]. In recent years, paediatric CC has
ontinued to be associated with complications, although the
verall incidence appears to be decreasing. Independent risk
actors for a complication include young age (< 6months),
ale sex, inpatient status and the year of catheterization
36,37].
More common complications for each interventional pro-
edure are summarized in the literature [3—5,31,38,39].
s it necessary to inform parents and the
hild about the risks of ionizing radiation
uring paediatric cardiac catheterization?
C is one of the radiological X-ray procedures with the high-
st doses of radiation. This is of great concern in a paediatric
etting because of the higher tissue sensitivity in infants and
hildren. Infants and children are at least three times more
ensitive than adults to radiation-induced malignancies [40].
Over the last few years, an increasing number of ther-
peutic catheterization procedures have been performed
n children. Interventional cardiology procedures are known
o give high-doses of radiation to patients because of pro-
onged ﬂuoroscopy, multiple cine runs and the complexity
f the procedures. Moreover, in children with congenital
eart disease, there is often a need to perform multiple
xaminations, thus increasing the radiation damage [41,42].
ccording to the European Council Directive 97/43/Erra-
um of 30 June 1997, all member states shall promote the
stablishment and use of diagnostic reference levels for
adiographic examinations [43].
Article 9 of that directive expressly requires special
ttention to be paid to the radiological exposure of chil-
ren and interventional radiology. There are few studies
n the exposure of children to radiation during CC and its
ependency on growth.
Because of the moderate values of doses in paediatric
C, radiation-induced skin injuries are unlikely. To assess
he potential risk of stochastic effects such as cancer and
eukaemia resulting from CC procedures, the effective dose
hould be calculated. However, to assess the potential risk
f stochastic effects resulting from CC procedures, the
ffective dose can be calculated with the multiplicative
odel recommended in the International Commission on
adiological Protection Publication 60, which used age and
ex-dependent risk factors (13%/Sv for boys and 16%/Sv for
irls aged 10 years) [44] [this refers to Publication 103].
Determining the effective dose in CC procedures is not
traightforward because of the complexity of the X-ray
eam geometry and ﬁeld size variations during examina-
ions. Moreover, individual anatomy should be taken into
ccount. Anatomy is very important for dose estimations
n children because patients’ weights and heights may vary
onsiderably. Using only the standard paediatric mathemati-
al phantoms of 0, 1, 5, 10 and 15 years could result in errors
s large as 25% [40].
b
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The overall correlation between radiation risk and
atient’s age was poor. However, a much higher median risk
stimate was found, as there was a signiﬁcant increase in
ffective dose with decreasing age [41,42].
Risk estimates for late effects in these patients have
een based on the linear extrapolation of high-dose data
s obtained in the lifespan study of atomic bomb survivors:
he linear-no-threshold model. The concept ignores any self-
ealing process by the cell and the affected organism. These
ssumptions are increasingly called into question in the lit-
rature.
Various studies in the literature suggest, via the use of
biomarker (from circulating lymphocytes), that low doses
f radiation have a deleterious effect on deoxyribonucleic
cid (DNA). Studies of these biomarkers seem to show long-
asting effects of chromosomal damage in children with
ongenital heart disease [45]. The use of -H2AX foci as
biomarker of DNA damage suggests that the risk of can-
er calculated according to the linear-no-threshold model is
ossibly underestimated [46] (Table 2).
Leukaemia and cerebral tumours are rare cancers with a
ow cumulative absolute risk. Recently, Pearce et al. showed
hat for a cumulative delivered dose of 50—60mGy during
omodensitometry in a cohort of children and young adults,
he risk of leukaemia and cerebral tumours was multiplied
y three [47].
hat is known about the risk of stochastic
ffects during paediatric cardiac
atheterization?
o answer this question a national multicentre study is cur-
ently being ﬁnalized under the auspices of the Institut
ational de Radioprotection et de Sûreté Nucléaire.
Despite its limits, the linear-no-threshold model has a
seful regulatory role because it can be applied to form a
imple and effective framework for radioprotection (as low
s reasonably achievable [ALARA] principle) [48].
The goal of the ALARA concept as applied to CC is to
rovide maximal diagnostic and therapeutic beneﬁts while
xposing patients to the lowest possible dose of radiation.
echniques and strategies to manage radiation doses are
etailed in the literature and enable the paediatric cardiol-
gist to produce high-quality images at low radiation cost to
he patient [46].
Data in the literature emphasize that when managing
serious condition, such as complex congenital heart dis-
ase, we also have to protect patients from risks that may
ecome clinically manifest after years and even decades. We
hould justify the indication and optimize dose delivery by
djusting doses, reducing multiple scans and contrast agents
nd eliminating inappropriate referrals. Recently, a paper
eviewed how physicians could meet the ideals of informed
onsent with regard to cardiac imaging with ionizing radia-
ion, given the limited evidence of risks and beneﬁts. The
oal is to have an informed patient making rational choices
ased on available medical information [49].
These practices have been recommended internationally.
n Europe, the principles of justiﬁcation, optimization and
esponsibility are also reinforced by the Erratum law [43].
Paediatric cardiac catheterization: An information sheet 235
Table 2 Potential clinical effects of radiation exposure [49].
Threshold dose (Gy) Time of onset
Skin effects
Early transient erythema 2 2—24 hours
Mean erythema reaction 6 1.5weeks
Temporary depilation 3 3weeks
Permanent depilation 7 3weeks
Dermal necrosis > 12 > 52weeks
Eye effects
Lens opacity > 1—2 > 5 years
Cataract > 5 > 5 years
Gy: gray.
[
[
[
[In France, these principles were included in the CSP in 2002
[50].
Conclusion
Before implementing diagnostic or therapeutic strategies,
such as paediatric CC, the healthcare professional must
explain the disease, the advantages and drawbacks of each
treatment strategy and their foreseeable beneﬁt/risk ratio
in order to help children and their parents to come to a
decision. An information sheet cannot replace verbal infor-
mation. This information should be based on scientiﬁc data
derived from practice guidelines and be made available in
formats suited to several target audiences. In the event of
complications, the healthcare provider must prove that the
information was provided and explained.
Practice patterns such as justiﬁcation, optimization and
responsibility have been recommended and were included
in the PHC in 2002.
Ten years after the law of 4th March 2002, developments
concerning information are expected. These will probably
reinforce both the autonomy of patients in their choices
and the obligation of the healthcare provider to provide the
information necessary to obtain informed consent.
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